Renoprotection With SGLT2 Inhibitors in Type 2 Diabetes Over a Spectrum of Cardiovascular and Renal Risk
Liraglutide ameliorates beta-cell function, alleviates oxidative stress and inhibits low grade inflammation in young patients with new-onset type 2 diabetes
AstraZeneca Eli Lilly and Company Novo Nordisk Sanofi Biocon *Disclaimer: Top companies sorted in no particular order Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists Market Concentration Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists Company List Novo Nordisk AstraZeneca Eli Lilly and Company Sanofi Biocon Novartis Want to use this image
Acute Gallbladder Disease: Wegovy may cause gallbladder problems, including gallstones
For patients undergoing colonoscopy, who were on clear liquid diets the day prior, no clinically significant residual gastric volume was found in either group
Brabander T, van der Zwan WA, Teunissen JJM, Kam BLR, Feelders RA, de Herder WW, et al